نتایج جستجو برای: donepezil hydrochloride

تعداد نتایج: 45696  

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2016
Ryota Takeuchi Kohki Shinozaki Takeo Nakanishi Ikumi Tamai

Clinical reports indicate that cardiotoxicity due to donepezil can occur after coadministration with cilostazol. We speculated that the concentration of donepezil in heart tissue might be increased as a result of interaction with cilostazol at efflux transporters such as P-glycoprotein (P-gp, ABCB1) and breast cancer resistance protein (BCRP, ABCG2), which are expressed in many tissues includin...

Journal: :The Lancet. Neurology 2015
Robert Howard Rupert McShane James Lindesay Craig Ritchie Ashley Baldwin Robert Barber Alistair Burns Tom Dening David Findlay Clive Holmes Robert Jones Roy Jones Ian McKeith Ajay Macharouthu John O'Brien Bart Sheehan Edmund Juszczak Cornelius Katona Robert Hills Martin Knapp Clive Ballard Richard G Brown Sube Banerjee Jessica Adams Tony Johnson Peter Bentham Patrick P J Phillips

BACKGROUND Findings from observational studies have suggested a delay in nursing home placement with dementia drug treatment, but findings from a previous randomised trial of patients with mild-to-moderate Alzheimer's disease showed no effect. We investigated the effects of continuation or discontinuation of donepezil and starting of memantine on subsequent nursing home placement in patients wi...

ژورنال: طب جنوب 2020
Azami , Nasrin Sadat, Ebadi , Mehdi, Heidari , Mahmood,

Background: Progressive neurodegeneration of nervous system as well as learning and memory disorders is characteristics of Alzheimer’s disease. Drug delivery is one of the research aspects for improving treatment of diseases. Chitosan nanoparticles were used for Donepezil transportation and its effect on dimproving amnesia was investigated. Materials and Methods: In this experimental study, 13...

Journal: :The international journal of neuropsychopharmacology 2009
Masatomo Ishikawa Muneyuki Sakata Kenji Ishii Yuichi Kimura Keiichi Oda Jun Toyohara Jin Wu Kiichi Ishiwata Masaomi Iyo Kenji Hashimoto

The acetylcholinesterase (AChE) inhibitor donepezil is also a sigma1 receptor agonist. We examined whether donepezil binds to sigma1 receptors in the living human brain after a single oral administration. Dynamic positron emission tomography (PET) data acquisition using the selective sigma1 receptor ligand [11C]SA4503 was performed to evaluate quantitatively the binding of [11C]SA4503 to sigma1...

2006
Joanne Knowles

INTRODUCTION Donepezil is indicated for the symptomatic treatment of mild to moderate Alzheimer's disease. It is a specific and reversible inhibitor of acetylcholinesterase (AChE); by increasing levels of available acetylcholine, donepezil may compensate for the loss of functioning cholinergic brain cells. AIMS This review evaluates the clinical impact of donepezil by assessing randomized con...

Journal: :The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2015
Jared R Tinklenberg Helena C Kraemer Kristine Yaffe Ruth O'Hara John M Ringman John W Ashford Jerome A Yesavage Joy L Taylor

OBJECTIVE To compare the outcome of donepezil treatment in ethnically diverse Alzheimer disease (AD) patients with ethnically diverse AD patients who did not receive donepezil. METHODS Patients meeting NINCDS-ADRA criteria for probable or possible AD from a consortium of California sites were systematically followed for at least 1 year in this prospective, observational study. Their treatment...

Journal: :Postgraduate medicine 1999
K A Welsh-Bohmer J C Morgenlander

Improved understanding of neurobehavior in normal aging, Alzheimer's disease, and late-life depression makes early detection of neurodegenerative conditions possible. Primary care physicians can screen patients' mental status and mood states with simple in-office tests. When screening results or the clinical picture is ambiguous or complex, neuropsychological evaluation is useful in making an e...

2000
Hachiro Sugimoto

A wide range of evidence show that acetylcholinesterase (AChE) inhibitors can interfere with the progression of Alzheimer's Disease (AD). The successful development of these compounds was based on a well-accepted theory that the decline in cognitive and mental functions associated with AD is related to the loss of cortical cholinergic neurotransmission. The earliest known AChE inhibitors, namel...

Journal: :Neuropharmacology 2017
Maria Amat-Foraster Steven C. Leiser Kjartan F. Herrik Nelly Richard Claus Agerskov Christoffer Bundgaard Jesper F. Bastlund Inge E.M. de Jong

The 5-HT6 receptor is a promising target for cognitive disorders, in particular for Alzheimer's disease (AD). The high affinity and selective 5-HT6 receptor antagonist idalopirdine (Lu AE58054) is currently in development for mild-moderate AD as adjunct therapy to acetylcholinesterase inhibitors (AChEIs). We studied the effects of idalopirdine alone and in combination with the AChEI donepezil o...

Journal: :The Journal of pharmacology and experimental therapeutics 2009
Noriko Narimatsu Naoaki Harada Hiroki Kurihara Naomi Nakagata Kazuya Sobue Kenji Okajima

Insulin-like growth factor-I (IGF-I) exerts beneficial effects on cognitive function. The selective acetylcholinesterase inhibitor donepezil increases serum IGF-I levels in elderly subjects. Because stimulation of sensory neurons induces IGF-I production by releasing calcitonin gene-related peptide (CGRP) in the mouse brain, we hypothesized that donepezil increases IGF-I production by sensory n...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید